The NLR gene family: from discovery to present day

WC Chou, S Jha, MW Linhoff, JPY Ting - Nature Reviews Immunology, 2023 - nature.com
The mammalian NLR gene family was first reported over 20 years ago, although several
genes that were later grouped into the family were already known at that time. Although it is …

[HTML][HTML] Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance

Y Liu, H Lei, W Zhang, Q Xing, R Liu, S Wu, Z Liu… - Cell Death & …, 2023 - nature.com
Pyroptosis is a novel inflammatory form of regulated cell death (RCD), characterized by cell
swelling, membrane rupture, and pro-inflammatory effects. It is recognized as a potent …

[HTML][HTML] Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer

J Yang, J Mo, J Dai, C Ye, W Cen, X Zheng… - Cell death & …, 2021 - nature.com
Cetuximab is approved for the treatment of metastatic colorectal cancer (mCRC) with RAS
wild-type. Nevertheless, the prognosis remains poor and the effectiveness of cetuximab is …

Extracellular vesicles derived from melatonin‐preconditioned mesenchymal stem cells containing USP29 repair traumatic spinal cord injury by stabilizing NRF2

W Liu, P Tang, J Wang, W Ye, X Ge… - Journal of Pineal …, 2021 - Wiley Online Library
Spinal cord injury (SCI) is a devastating trauma that leads to irreversible motor and sensory
dysfunction and is, so far, without effective treatment. Recently, however, nano‐sized …

[HTML][HTML] The cytokine network in colorectal cancer: Implications for new treatment strategies

H Braumüller, B Mauerer, J Andris, C Berlin, T Wieder… - Cells, 2022 - mdpi.com
Colorectal cancer (CRC) is one of the most frequent tumor entities worldwide with only
limited therapeutic options. CRC is not only a genetic disease with several mutations in …

[HTML][HTML] The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via …

F Luo, H Li, W Ma, J Cao, Q Chen, F Lu, M Qiu… - Cellular & Molecular …, 2024 - nature.com
The main challenges in the use of immune checkpoint inhibitors (ICIs) are ascribed to the
immunosuppressive tumor microenvironment and the lack of sufficient infiltration of activated …

[HTML][HTML] USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma

W Qiu, Z Xiao, Y Yang, L Jiang, S Song, X Qi… - Cell Death & …, 2023 - nature.com
The mesenchymal (MES) subtype of glioblastoma (GBM) is a highly aggressive, malignant
and proliferative cancer that is resistant to chemotherapy. Runt-related transcription factor 1 …

[HTML][HTML] Identification and exploration of pharmacological pyroptosis-related biomarkers of ulcerative colitis

K Chen, S Shang, S Yu, L Cui, S Li, N He - Frontiers in Immunology, 2022 - frontiersin.org
Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD). Its etiology is unclear.
Much evidence suggests that the death of abnormal intestinal epithelial cells (IECs) leads to …

[HTML][HTML] Deubiquitinases in cancers: aspects of proliferation, metastasis, and apoptosis

J Liu, CT Leung, L Liang, Y Wang, J Chen, KP Lai… - Cancers, 2022 - mdpi.com
Simple Summary This review summarizes the current DUBs findings that correlate with the
most common cancers in the world (liver, breast, prostate, colorectal, pancreatic, and lung …

[HTML][HTML] Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer

Q Zou, X Lei, A Xu, Z Li, Q He, X Huang, G Xu… - Frontiers in …, 2022 - frontiersin.org
Plenty of factors affect the oncogenesis and progression of colorectal cancer in the tumor
microenvironment, including various immune cells, stromal cells, cytokines, and other …